Another study reported that ROMO1 expression in prostate cancer was also associated with immune cells infiltrating the tumor, leading to changes in the tumor microenvironment and further increasing tumor heterogeneity [28]. This evidence concerns the gene ROMO1 and prostate carcinoma.